Govt May Bring Surgical Gloves Under Quality Control Order

New Delhi: The government is likely to bring surgical gloves and single-use medical examination gloves under the Quality Control Order (QCO) to check imports of poor-quality products and ensure better standards for those manufactured in the country.

The move is in line with demands raised by domestic glove makers who said the lack of proper regulation is resulting in import of substandard gloves, rejected in other countries, to India.

The issue of bringing these gloves under QCO-raised by Indian Rubber Gloves Manufacturers Association -was discussed at a meeting held by the Department of Consumer Affairs (DoCA) last week. The Department of Pharmaceuticals (DoP) is considering the issuance of QCO in consultation with the Bureau of Indian Standards and has invited comments, according to the minutes of the meeting.

In a bid to resolve this issue that is posing a health hazard for doctors, medical staff and patients, and to save the domestic industry from unfair trade practices, the DoCA pressed upon the need to issue QCA. Glove makers said poor-quality bulk-packed items from countries like Thailand, Malaysia and China are being dumped in India under different non-medical HSN codes and are then repacked for medical usage here.

“Earlier, India’s drug regulatory authority had mandated that medical examination gloves meet requirements of quality standards. However, it did not notify the BIS labs in its list of quality labs,” a person in the know told ET.

Related Posts

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre